Characteristic; indication | Group; mean ± SD | p value | |
---|---|---|---|
PRA | TLA | ||
Gland size, cm | |||
All tumour types | 5.3 ± 1.5 | 6.2 ± 2.6 | 0.2* |
Excluding pheochromocytoma | 5.3 ± 1.4 | 6.0 ± 1.8 | 0.1 |
Pheochromocytoma | 6.0 ± 2.1 n = 5 | 6.6 ± 3.3 | 0.6 |
Primary aldosteronism | 5.2 ± 1.2 | 5.3 ± 2.1 | 0.9 |
Cushing syndrome | 4.5 ± 1.5 | 8.0 ± 1.7 | 0.05 |
Nonfunctional | 6.7 ± 1.5 | 6.0 ± 1.2 | 0.4 |
Gland weight, g | |||
All tumour types | 19.2 ± 13.9 | 63.4 ± 65.5 | < 0.001† |
Excluding pheochromocytoma | 19.3 ± 14.4 | 64.5 ± 55.4 | 0.001† |
Pheochromocytoma | 18.6 ± 9.7 n = 5 | 61.9 ± 80.0 | 0.02* |
Primary aldosteronism | 16.9 ± 12.6 | 38.0 ± 43.9 | 0.1† |
Cushing syndrome | 16.4 ± 9.2 | 132.0 ± 56.6 | 0.002* |
Nonfunctional | 35.2 ± 19.1 | 65.6 ± 48.9 | 0.3* |